
CDMO News
Aurigene to Provide Cell Therapy Discovery Services to Edity Therapeutics
Aurigene Pharmaceutical Services, an India-based contract research, development, and manufacturing organisation (CRO/CDMO), announced on 1 July 2024 that it will provide discovery services in cell therapy to Edity Therapeutics, an Israeli company. This collaboration is designed to support and speed
